Showing results (121-130 of 183) with videos related to

Sort By:
Pageof 19
Neuro-Oncology|December 28, 2020
Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumorsEmilie Le Rhun, Patrick Devos, Johannes Weller, et al.
Future Oncology (London, England)|May 28, 2021
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trialAlessandra Fabi, Irene Terrenato, Antonello Vidiri, et al.
European Journal of Cancer (Oxford, England : 1990)|August 13, 2021
Patient-reported outcomes in a phase II randomised study of regorafenib compared with lomustine in patients with relapsed glioblastoma (the REGOMA trial)Giuseppe Lombardi, Paola Del Bianco, Alba A Brandes, et al.
Journal of Neuro-Oncology|March 18, 2025
Education paths in neuro-oncology: combining technical skills with multidisciplinary care. A survey from the AINO (Italian Association for Neuro-Oncology) Youngster CommitteeRina Di Bonaventura, Denis Aiudi, Silvia Chiesa, et al.
Neuro-Oncology Advances|July 30, 2025
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trialJulia Furtner, Luzia Berchtold, Emilie Le Rhun, et al.
Neuro-Oncology|October 13, 2020
Association of supratotal resection with progression-free survival, malignant transformation, and overall survival in lower-grade gliomasMarco Rossi, Lorenzo Gay, Federico Ambrogi, et al.
Journal of Neuropathology and Experimental Neurology|January 29, 2019
Prognostic Characterization of Higher-Grade Meningiomas: A Histopathological Score to Predict Progression and OutcomeLuca Bertero, Giulia Dalla Dea, Simona Osella-Abate, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 23, 2021
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experienceLuca Diamanti, Alberto Picca, Paola Bini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 25, 2024
ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse gliomaBrigitta G Baumert, Jaap P M Jaspers, Vera C Keil, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2020
Phosphorylated Acetyl-CoA Carboxylase Is Associated with Clinical Benefit with Regorafenib in Relapsed Glioblastoma: REGOMA Trial Biomarker AnalysisStefano Indraccolo, Gian Luca De Salvo, Martina Verza, et al.
Pageof 19